Author:
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 70
Book Description
Product Profile
Author:
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 70
Book Description
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 70
Book Description
Target product profiles for needed antibacterial agents
Author:
Publisher: World Health Organization
ISBN: 9240003894
Category : Medical
Languages : en
Pages : 32
Book Description
Publisher: World Health Organization
ISBN: 9240003894
Category : Medical
Languages : en
Pages : 32
Book Description
한철학사
Author: 최민홍
Publisher:
ISBN: 0901690546
Category :
Languages : en
Pages : 518
Book Description
Publisher:
ISBN: 0901690546
Category :
Languages : en
Pages : 518
Book Description
Target product profile for a low-cost test for use in bacterial meningitis outbreak response and surveillance
Author: World Health Organization
Publisher: World Health Organization
ISBN: 924008908X
Category : Medical
Languages : en
Pages : 26
Book Description
Publisher: World Health Organization
ISBN: 924008908X
Category : Medical
Languages : en
Pages : 26
Book Description
Target product profile for drugs to prevent spontaneous preterm birth
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240081232
Category : Medical
Languages : en
Pages : 20
Book Description
Preterm birth (i.e. birth before 37 completed weeks of gestation) is the leading cause of neonatal mortality globally. There is an urgent need for new agents to prevent preterm birth, thereby reducing adverse outcomes for newborns. An initial target product profile (TPP) for drugs to prevent spontaneous preterm birth was developed and published by external parties. Following the identification of an unmet public health need, WHO has considered the already published TPP as the basis for developing a WHO TPP. The purpose of this TPP is to guide product developers and funders on the key characteristics and desired attributes of preventive agents that should be administered to pregnant women at increased risk of spontaneous preterm birth. This TPP outlines the minimal and preferred characteristics of a medicine that should: - reduce the likelihood of preterm birth and thus prevent (or mitigate) adverse newborn outcomes due to prematurity; - have an excellent safety profile during pregnancy; - be suitable for prescription or administration by skilled health personnel in any health care setting where pregnant women receive antenatal care, including in LMICs; - be commenced early in pregnancy and can be continued throughout pregnancy, as required.
Publisher: World Health Organization
ISBN: 9240081232
Category : Medical
Languages : en
Pages : 20
Book Description
Preterm birth (i.e. birth before 37 completed weeks of gestation) is the leading cause of neonatal mortality globally. There is an urgent need for new agents to prevent preterm birth, thereby reducing adverse outcomes for newborns. An initial target product profile (TPP) for drugs to prevent spontaneous preterm birth was developed and published by external parties. Following the identification of an unmet public health need, WHO has considered the already published TPP as the basis for developing a WHO TPP. The purpose of this TPP is to guide product developers and funders on the key characteristics and desired attributes of preventive agents that should be administered to pregnant women at increased risk of spontaneous preterm birth. This TPP outlines the minimal and preferred characteristics of a medicine that should: - reduce the likelihood of preterm birth and thus prevent (or mitigate) adverse newborn outcomes due to prematurity; - have an excellent safety profile during pregnancy; - be suitable for prescription or administration by skilled health personnel in any health care setting where pregnant women receive antenatal care, including in LMICs; - be commenced early in pregnancy and can be continued throughout pregnancy, as required.
Target product profile for drugs to manage preterm labour
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240081259
Category : Medical
Languages : en
Pages : 20
Book Description
Preterm birth (i.e. birth before 37 completed weeks of gestation) is the leading cause of neonatal mortality globally. Preterm newborns that survive are at an increased risk of a number of short- and long-term adverse health outcomes, including chronic lung disease, infections and neurological, visual and auditory disabilities. A number of tocolytic agents are currently in use internationally to slow down or stop the progression of labour. However, none of those has shown substantive improvements in fetal or newborn health outcomes.There is an urgent need for new agents to manage preterm birth, thereby reducing adverse outcomes for newborns. An initial target product profile (TPP) for drugs to manage preterm labour was developed and published by external parties. Following the identification of an unmet public health need, WHO has considered the already published TPP as the basis for developing a WHO TPP. The purpose of this TPP is to guide product developers and funders on the key characteristics and desired attributes of therapeutic agents for pregnant women experiencing spontaneous preterm labour.
Publisher: World Health Organization
ISBN: 9240081259
Category : Medical
Languages : en
Pages : 20
Book Description
Preterm birth (i.e. birth before 37 completed weeks of gestation) is the leading cause of neonatal mortality globally. Preterm newborns that survive are at an increased risk of a number of short- and long-term adverse health outcomes, including chronic lung disease, infections and neurological, visual and auditory disabilities. A number of tocolytic agents are currently in use internationally to slow down or stop the progression of labour. However, none of those has shown substantive improvements in fetal or newborn health outcomes.There is an urgent need for new agents to manage preterm birth, thereby reducing adverse outcomes for newborns. An initial target product profile (TPP) for drugs to manage preterm labour was developed and published by external parties. Following the identification of an unmet public health need, WHO has considered the already published TPP as the basis for developing a WHO TPP. The purpose of this TPP is to guide product developers and funders on the key characteristics and desired attributes of therapeutic agents for pregnant women experiencing spontaneous preterm labour.
Target product profile for therapy of diagnosed uncomplicated gonorrhoea
Author:
Publisher: World Health Organization
ISBN: 9240003819
Category : Medical
Languages : en
Pages : 8
Book Description
Publisher: World Health Organization
ISBN: 9240003819
Category : Medical
Languages : en
Pages : 8
Book Description
Diagnostic target product profiles for monitoring and evaluation of soil-transmitted helminth control programs
Author:
Publisher: World Health Organization
ISBN: 9240031227
Category : Medical
Languages : en
Pages : 18
Book Description
Publisher: World Health Organization
ISBN: 9240031227
Category : Medical
Languages : en
Pages : 18
Book Description
Target product profile for therapy of uncomplicated enteric fever
Author:
Publisher: World Health Organization
ISBN: 9240003835
Category : Medical
Languages : en
Pages : 8
Book Description
Publisher: World Health Organization
ISBN: 9240003835
Category : Medical
Languages : en
Pages : 8
Book Description
Omics and Biotechnological Approaches for Product Profile-Driven Sorghum Improvement
Author: Ephrem Habyarimana
Publisher: Springer Nature
ISBN: 9819743478
Category :
Languages : en
Pages : 457
Book Description
Publisher: Springer Nature
ISBN: 9819743478
Category :
Languages : en
Pages : 457
Book Description